Global High Growth Potential Companies

CD Projekt

Market Cap: zł25.2b

Together its subsidiaries, engages in the development, publishing, and digital distribution of video games for personal computers and video game consoles in Poland.

I.CO.P.. Società Benefit

Market Cap: €560.4m

Engages in providing construction and special engineering services to public and private clients in Italy and internationally.

Pharma Mar

Market Cap: €1.4b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Novavis Group

Market Cap: zł44.5m

Engages in developing, designing, and executing renewable energy sources projects in Poland.

Fawry for Banking Technology and Electronic PaymentsE

Market Cap: ج.م46.5b

Fawry for Banking Technology and Electronic Payments S.A.E.

ErreDue

Market Cap: €45.3m

Offers on-site production, mixing, and purification of technical gases solutions in Italy.

Guinness Nigeria

Market Cap: ₦307.1b

Engages in brewing, packaging, marketing, and selling whisky, vodka, liqueur, gin, spirits, beers, non-alcoholic drinks, and ready-to-drink products primarily in Nigeria.

eWeLLLtd

Market Cap: JP¥43.2b

Develops business support cloud services for visiting nursing stations in Japan.

Synspective

Market Cap: JP¥98.7b

Designs, builds, and operates a fleet of synthetic aperture radar satellites (SAR) to detect and understand changes.

Construtora Tenda

Market Cap: R$2.6b

Operates as a construction company in Brazil.

Rheinmetall

Market Cap: €71.4b

Provides mobility and security technologies in Germany; the rest of Europe; North, Middle, and South America; Asian regions, and internationally.

Intellego Technologies

Market Cap: SEK 4.5b

Manufactures and sells colorimetric ultraviolet indicators in Sweden.

Alkami Technology

Market Cap: US$2.3b

Provides cloud-based digital banking solutions in the United States.

TG Therapeutics

Market Cap: US$4.1b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Lumentum Holdings

Market Cap: US$8.2b

Manufactures and sells optical and photonic products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.

AVITA Medical

Market Cap: US$129.4m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Hesai Group

Market Cap: US$3.4b

Through with its subsidiaries, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally.

Alnylam Pharmaceuticals

Market Cap: US$60.1b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

KebNi

Market Cap: SEK 572.1m

Develops, produces, and sells products and applications for stabilization, navigation, and satcom worldwide.

Visual Photonics Epitaxy

Market Cap: NT$25.1b

Engages in the research and development, manufacture, and sale of optoelectronic semiconductors epitaxy and optoelectronic components products in Taiwan, the United States, and internationally.

Gold Circuit Electronics

Market Cap: NT$215.8b

Designs, manufactures, processes, and distributes printed circuit boards in Taiwan.

Propel Holdings

Market Cap: CA$1.3b

Operates as a financial technology company.

Carvana

Market Cap: US$75.1b

Operates an e-commerce platform for buying and selling used cars in the United States.

Credo Technology Group Holding

Market Cap: US$18.2b

Provides various high-speed connectivity solutions for optical and electrical Ethernet, and PCIe applications in the United States, Taiwan, Mainland China, Hong Kong, and internationally.

Zevra Therapeutics

Market Cap: US$505.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Cox ABG Group

Market Cap: €845.2m

Operates as an integrated utility of water and energy company.

Altea Green Power

Market Cap: €146.2m

Provides renewable energy systems for individuals, companies, institutions and investors in Italy.

Axsome Therapeutics

Market Cap: US$5.6b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

M Vest Water

Market Cap: NOK 291.2m

An environmental technology company, develops products and solutions for the water treatment industry in Norway, Iceland, Austria, Switzerland, and Oman.

Cadeler

Market Cap: NOK 19.0b

Engages in offshore wind farm installation, operations, and maintenance services in Denmark.

Elliptic Laboratories

Market Cap: NOK 1.3b

An artificial intelligence (AI) software company, engages in the provision of AI virtual smart sensors for the smartphone, laptop, Internet of Things, and automotive markets in Norway, the United States, China, South Korea, Taiwan, and Japan.

Ascendis Pharma

Market Cap: US$11.8b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.

Travere Therapeutics

Market Cap: US$1.6b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$98.5b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Pop Mart International Group

Market Cap: HK$419.7b

An investment holding company, engages in the design, development, and sale of pop toys in the People’s Republic of China, Hong Kong, Macao, Taiwan, and internationally.

CARsgen Therapeutics Holdings

Market Cap: HK$11.7b

An investment holding company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies, solid tumors, and autoimmune diseases in China.